InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read MorePosted by Melanie Hamilton-Basich | Oct 20, 2020 | Covid 19, Mass Spectrometry |
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read MorePosted by Laurie Bonner | Oct 19, 2020 | Covid 19, Hematology & Serology |
The team tested alternative ways to measure covid-19 antibody levels, resulting in a process that is faster, easier, and less expensive to use on a large scale.
Read MorePosted by Laurie Bonner | Oct 13, 2020 | Compliance, Covid 19, Flu & Respiratory Infections |
The FDA has issued and immediately implemented a new guidance: Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.
Read MorePosted by Melanie Hamilton-Basich | Oct 9, 2020 | Covid 19, Standards |
The agency has issued cease-and-desist letters to laboratories conducting covid-19 testing without appropriate certification.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Molecular Diagnostics |
LabCorp’s new, high-throughput method uses heat and technology to extract RNA from samples collected for covid-19 molecular testing.
Read More